Biopharma
ByDid 2025 Expose the Breaking Point of America’s Health Care System?
New reflections from healthcare leaders highlight how events in 2025 revealed deep structural weaknesses in the U.S. health…
U.S. FDA Approves JASCAYD® for Progressive Pulmonary Fibrosis – A New Treatment Option for Adults?
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved JASCAYD® (nerandomilast) tablets for the…
Has the FDA Approval of Breyanzi Expanded CAR T Cell Therapy Options for Marginal Zone Lymphoma Patients?
Bristol Myers Squibb has received approval from the U.S. Food and Drug Administration for Breyanzi, a CD19-directed CAR…
Does a New Kidney Cancer Trial Expand Long-Term Oncology Optionality for Bristol-Myers Squibb and BioNTech?
December 2025 — Bristol-Myers Squibb and BioNTech have announced progress in their oncology collaboration with the initiation of…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma in Japan?
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan for Dupixent (dupilumab)…
Will Novartis’ $280M Gene Therapy Plant Transform Denton into a Biopharma Hub?
Denton, TX The Denton City Council has unanimously approved an economic development agreement with Novartis Gene Therapies, paving…
